Wow, that is just sad and pathetic. I just saw the 1-A.

Forget about pennies. You were right about the "news." I should have been more suspicious.

First of all, aren't publicly traded companies generally obligated to publicly announce agreements that they have? Otherwise insiders and very savvy investors would have the upper hand.

Secondly, the first run up created a lot of bagholders. In addition, there were a lot of people who bought on the initial spike (October 11) that closed at 0.0027. Oct 11 was a 2B volume day.

So I don't see this press release as a "pump." Rather, there was some volume on the news and then bagholders and disenchanted buyers unloaded.

Either way I still think this is gonna run to pennies. By hook, or by crook!

Pinnacle consulting services

Firstly, this is straight from the filings:

October 7, 2021, CEO Gregory C. Manos entered into a Stock Purchase Agreement as the Seller of his 10,000 shares of Preferred Stock.
The Purchaser, Glen Bonilla, purchased the 10,000 shares of Preferred Stock at a purchase price of $1.00 per share, for $10,000.
Gregory Manos entered a consulting agreement for services rendered on October 7, 2021. Mr. Manos is entitled to receive $5,000 in
compensation.

Pinnacle Consulting Services Inc. entered into a consulting services agreement for $450,000 that was due and owed on October 7, 2021.
The invoice pertaining to this agreement is delinquent as of the date of this filing.

What has happened here is that Manos engaged Pinnacle Consulting Services (https://www.pinnacleconsultingservicesinc.com/) to help him clean up the AHFD shell. Pinnacle are the ones that must have brought Manos and Bonilla in touch. When Manos sold control of AHFD to Bonilla through the super voting preferred, the Pinnacle invoice became due. As the filings say, Pinnacle is owed $450,000. How and when is that going to be paid back?

Secondly there is no dilution yet. In early 2021 AHFD issued 1 billion shares each to Union Capital and Adar Bays. This was to eliminate convertible debt, which it did. Those issuances brought the OS to 7.9B. It has not changed as of 10/20. It could be that shares will be issued to pay Pinnacle but there is no evidence of that yet.

But don't Etrade and TD charge $6.95 per trade? So if you buy a couple million in the trips or low 0.00s and try to unload 10-100K at a time, you get slapped in the face by fees.

Anyway, TD is now owned by Schwab. As far as I know, with the new rules now, there is nothing you can buy on TD that you can't buy on Schwab.

I like CoinChamps, but does anyone have any idea how many users the app has and what the revenue is? Just a rough estimate. I'm not convinced it's as huge as some are saying right now though I do like it in the longer term.

Also do we know for sure that AHFD had no convertible debt? I thought there was some.

It is interesting that this has been bought on at least two occasions while on the expert market. If there really is a patent, someone out there will try to gain control and revive it. This could be a huge runner.

Does anyone know how to place unsolicited orders and/or with which broker? I might want to take a couple million at 0.0001.

That is a "shell risk" badge. Shell risk and shell are not the same thing.

AHFD is a "shell", and has been since the end of August.

If you want to see something with a "shell risk" you can look at d*u*t*v for example only. If AHFD is both of those things, the shell takes precedent.

No it wasn't.

See post 27079

Shell status has been there for a while though.

This looks like an old fashioned frontload!

Don't fully understand the dumping. Yes, the A/S was finally updated to 14.4B. But companies usually can't dilute without positive and good news to increase interest. BRNE isn't even pink current.

I could be wrong, but IMO something is going to happen here before the dilution starts.

Right, but that doesn't mean you have to sell the company. That's when you work the phone lines, show data, give presentations, and see what kind of partnerships and funding sources you can get. If the only offers are buyouts you still have a choice between being bought or getting better pre-trial data/work. It's hard, no doubt.

In the case of RGBP, I think, obviously, a buyout is the best hope and I hope it happens. RGBP is run by one person and there is no other company infrastructure as far as I know.

What I meant was, small biotechs accumulate a lot of debt so it's not wrong to say they're not doing well financially, but could still be bought out. You can have a "losing" biotech and a "promising" biotech - both can have enormous debt.

In reference to small biotechs not being bought out, I'm not sure what you mean by "never seen it happen." I can think of many examples, not least Moderna. Moderna was never bought out. They had numerous partnerships over the years, including AstraZeneca, and they also had very good financial support through some partners. But in no way was Moderna "bought out." They were never for sale.

"Big Pharma" will buy anything they think they can profit from, just like any other big company.

In any case, RGBP is a one man show right now and buyout is probably its best hope. I hope it happens - I own a bunch of shares.

Have you considered that a company like Mimivax doesn't want to be bought out? If you are a scientist and have a team that has put in the work to get to a certain point, why would you want to stop? You want to finish the puzzle, solve the problem.

At least one reason why small biopharma companies don't get bought out is because they're doing just fine on their own.

In contrast, one main reason for buyouts is because the companies have a good idea or proven technology that isn't getting anywhere because the company isn't doing well financially, is poorly managed, or has issues that prevent it from successfully operating on their own. In these cases, large companies may take on the risk and debt to access the technology.

Things looking up here IMO...hope big info is on the way!

AHFD would have made my top 10 this week were it not for the share structure being too large.

Did anyone else notice the changes to the company profile on OTCmarkets?

Under "Products and Services" it says:
Previously the Company had a line of Organic Beverages and a line of Organic Energy Bars.

Under "Company Facilities" it says:
Our production facility is Dr Nionz located at 1935 139th Street in Gardena CA. 90249

Dr. Nionz is a plastic injection molding company
https://nionz.com/

It looks to me like one possibility here is that Manos will indeed RM this into his plastics business.

They have the 2nd quarter from this year and an attorney letter. It's just a matter of time before it's pink current.

I saw the O/S was updated Saturday to over 4.2 billion, up from 3.78 billion.

What a dilution dump. That's 400 million shares - at 5 cents a share that's 20 million dollars.

Can someone explain this in detail?

Because it was too easy for common men to make money.

Barely moving on the last 10-Q and the O/S hasn't been updated since July 30.

In the old days that would have often implied some dilution. Not saying this is the case since I don't know, but Koos still owes 1.2 million to Chemdiv.

There are still some conversions going on, which is slowing it.

The O/S was up to almost 1.5 billion on August 20 and hasn't been updated since then.

IMO the conversions need to be all finished before this will really rise. Not sure when exactly that will happen but hopefully it won't take too long.

When is the last 10-Q going to drop?

I'll believe dollars when I see it.

If you're right, a lot of people here are going to be millionaires next week.

Why does August 15th matter? As I understand, this will be pink current as soon as the last Q drops. RGBP is a SEC reporting entity.

Now that's a spinning top if there ever was one

What reason do you have to think this won't be current? Every 10-Q and 10-K for the last few years has been put out. The only one remaining is for June 31st. All of these have been put out relatively quickly since July/August.

September 28 is over a month away.

The last Q will almost certainly come next week. What do you imagine would prevent that?

Excellent, I think we can trust that, since it's from OTC.

Look, I still think BRNE is worth a shot. I and others have posted reasons why.

But let me ask you this. If the Twitter account is real, why isn't it linked to the OTC Markets profile for BRNE? Even companies like L~T*N~C have an official twitter on their company profile page.

Next, if BRNE really had started mining operations in Indonesia and had set up all the infrastructure to do that, why on earth would they publicize it through a Twitter account with no previous posts and no clear link to the company? That's something they would want to broadcast clearly and loudly, not by some back channel twitter account promising more information.

IMO, someone pumped this yesterday, quite possibly fraudulently. That doesn't mean we can't buy based on the OTC verified profile, low float, and possible RM.

What reason do you have to think this is an EV play?

I only saw that on the twitter account, which most seem to think is fake.

Neither the company nor Filbert have ever given any indication that they are targeting the EV sector.

If the BRNE court case is closed in Nevada, which it appears to be based on a search, what happened to the debt and proposed share issuance? Did they ever hold a fairness hearing and was it denied?

If nothing happened, all that debt is still owed, and Filbert now has the ticker in his receivership. If he couldn't get the debt paid back, including the debt owed to his own companies, he has to have a plan. There's no reason to keep it updated on OTC and in Nevada otherwise. Unless the plan was for someone to pump the whole thing like yesterday, which I sure hope not.

Either way, betting on this stock ultimately depends on whether you trust Filbert to do something.

Not attacking you, but you should probably figure out how to post clearer, larger pictures.

Here is the court information

At present, Defendant BRNE has 400,000 authorized shares (probably a clerical error, they mean 400,000,000) with 319,336,594 outstanding. The Receiver plans to amend the Articles of Incorporation to authorize additional shares, and then issue those shares to the above referenced claimants pro-rata based on the current market price (currently $0.0006) for the BRNE shares. The Receiver intends to cause BRNE to issue shares to the claimants concurrent with a ruling on a hearing before the Eighth Judicial District Court of Clark County, Nevada based on Section 3(a)(10) of the Securities Act of 1933 seeking an order finding that the terms of the issuance are fair to those whom the securities will be issued such that the shares are exempted from registration and may be freely traded in the market. The Receiver tends to file and serve notice of the Section 3(a)(10) fairness hearing at the earliest opportunity.

Correct, however if you look in the Nevada SOS, the total number of common shares is 14,400,000,000.

All Filbert has to do is phone the TA and tell him what the new A/S will be at his convenience.

Big screenshot attached.

I'm not sure I believe that. If Manos had no intention of making it current whatsoever, why waste time getting the OTC profile updated, getting the TA verified, and reinstating the corporation in the Wyoming filings?

The stock hasn't budged enough in the last few months to be considered a P&D under those circumstances.

All IMO of course.

Who did you speak to? Are you going to share and post screenshots or is this yet another cryptic claim of inside info? It's so common around here, as you might know since you now think you know how OTC works.

The twitter account was created in 2010, well before Filbert was CEO. That would have been when Nils Ollquist was CEO.

As some of you may know, Filbert's company Shellbridge was defrauded by BRNE and Filbert sued him. Filbert won control of the ticker in court and has been "CEO" of the shell ever since. He has regularly paid to keep it updated on the Nevada SOS and has a verified profile, and I do believe he updated the OTC Markets profile today.

If you look at Asiaheadhunter's past posts, it is clear that he is hyping BRNE in his initial posts. That is because he had an investment in it. But once he was defrauded and was awarded the ticker his tone turned negative. He previously posted the judgment in favor of Filbert if you look in his past posts.

I am not going to make definitive statements, but I personally find the Twitter account suspicious.

Ah, company profile changes. Of course I didn't check there.

You got in just in time! For today at least. I wonder if Filbert will be back to accuse someone of a pump.

Sheesh. Who is loading right now?

Could this drop be due to some conversions? The company said they had reached an agreement with creditors to "settle the notes over time at a fixed price per share."

They never gave a wider time frame nor a pps for the conversion. Also the SS hasn't been updated since Friday.

Manos filed an original 2021 report in the Wyoming business portal on July 5th, three weeks ago. It is a one page document with basically no information other than being a statement of the company's existence and compliance with Wyoming business regulations.

That's all I can find.

Maybe Koos is a bum, I don't know. But you have just made a number of highly questionable statements about mRNA science.

"mRNA shine is quickly losing its luster as the vaccines are showing to have serious side effects, including death, and now showing a lose of effectiveness faster than anticipated with more break through cases being reported with the Delta strain."

Disagree completely.There have been no deaths determined to come from the vaccines. There is a VERY small risk of myocarditis from the mRNA vaccines but overall they have been hugely successful given the volume. The J&J vaccine has a risk of a blood clot and there is news out that it has been determined to be less effective against delta: https://www.nytimes.com/2021/07/20/health/coronavirus-johnson-vaccine-delta.html. The mRNA vaccines are objectively the best bet right now. Pfizer and Moderna are 95% and 94.1% protective against severe COVID infections. J&J is 57-72% depending on which country you're in. Astra Zeneca is unclear but maybe about 79%. That's a huge difference. The information is out there and easy to find. https://www.statnews.com/2021/02/02/comparing-the-covid-19-vaccines-developed-by-pfizer-moderna-and-johnson-johnson/

"It is also now being looked at if the vaccine itself is giving rise to the variants due to how the mRNA only codes for
one spike protein allowing the virus to mutate more quickly creating new strains."

Totally wrong. This sounds like something from a conspiracy theory. Virus variants primarily emerge from long-term infections where they have a long time period to mutate into a more potent form. See for example: https://www.scmp.com/news/world/africa/article/3136136/woman-hiv-had-covid-19-seven-months-virus-mutated-32-times-inside. It is impossible, literally, for the vaccine to cause a rise in variants since mutations in the viral genome occur as it is copied by the viral polymerase complex, which has nothing to do with spike protein. While it is true that COVID variants sometimes have slightly different coding sequences than the spike protein in the vaccine, the difference is miniscule, and the vaccines are enough to blunt severe infection even in breakthrough cases. Very, very few people who've been vaccinated end up hospitalized.

"Natural immunity doesn't show this as the body's immune system creates a more robust immune response than it does with the mRNA vaccine."

Misleading. What's your evidence? In fact viral spike proteins are masked during infection and vaccinated individuals are reported to have significantly better antibodies against the spike protein RBD domain and the S1 subunit. Now it's true that natural immunity has the benefit of providing antibodies against the nucleocapsid, which isn't in the vaccine, but antibody levels in people with natural immunity tend to be weak to RBD, allowing the possibility of latent infection or repeat infection. Here is an article plus a PDF on this exact topic:
https://www.news-medical.net/news/20210421/Antibody-response-induced-by-mRNA-vaccination-differs-from-natural-SARS-CoV-2-infection.aspx
https://www.biorxiv.org/content/10.1101/2021.04.15.440089v4.full.pdf